PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. The company is headquartered in Florham Park, New Jersey. Show more

303A COLLEGE ROAD EAST, PRINCETON, NJ, UNITED STATES, 08540, Suite 300, Princeton, NJ, 08540, USA

https://www.pdsbiotech.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

37.45M

52 Wk Range

$0.51 - $1.55

Previous Close

$0.67

Open

$0.67

Volume

124,721

Day Range

$0.66 - $0.70

Enterprise Value

32.82M

Cash

21.66M

Avg Qtr Burn

-4.372B

Insider Ownership

1.51%

Institutional Own.

9.13%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Versamune® HPV (PDS0101) + Keytruda Details Head and neck squamous cell carcinoma (HNSCC)	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Versamune® HPV + PDS01ADC + pembrolizumab Details Head and neck squamous cell carcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS01ADC + Radiation Therapy Details Prostate cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS01ADC + ICI Details Human papillomavirus	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Versamune® HPV (PDS0101) + Chemoradiation Details Cervical cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Versamune® HPV (PDS0101) + Keytruda (pembrolizumab) Details HPV+ oropharyngeal cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS01ADC + floxuridine (FUDR) via HAIP Details Metastatic colorectal cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS0301 + Docetaxel Details Cancer, Prostate cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS01ADC + Histone Deacetylase (HDAC) inhibitor Details Bladder cancer, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS01ADC Details Kaposi Sarcoma	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Versamune® MUC1 + PDS01ADC Details Metastatic colorectal cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PDS01ADC + Docetaxel Details Prostate cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.